New Zealand Brain Research Institute

Christchurch 8011

2 studies enrolling now · 10 studies all time

What they study most

Alzheimers Disease, Alzheimers Disease, Familial, Dementia, Huntington Disease, Huntington's Disease, Huntingtons Disease, MSA, Multiple System Atrophy, Parkinson's Disease (PD), Pure Autonomic Failure (PAF), Symptomatic Neurogenic Orthostatic Hypotension

Studies at this site

• A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation — Recruiting now
• A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation — Recruiting now
• Frequency of Selected Single Nucleotide Polymorphisms in Huntington Disease Gene Expansion Carriers — Completed
• GENERATION HD2. A Study to Evaluate the Safety, Biomarkers, and Efficacy of Tominersen Compared With Placebo in Participants With Prodromal and Early Manifest Huntington's Disease — Running, not enrolling
• Study of ATH434 in Participants with Multiple System Atrophy — Completed
• A Study to Evaluate the Efficacy and Safety of Intrathecally Administered RO7234292 (RG6042) in Participants With Manifest Huntington's Disease — Completed
• Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure — Stopped early
• Phase 3 Open-Label Extension Study of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure — Stopped early
• Clinical Effect of Ampreloxetine (TD-9855) for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure — Completed
• Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E) — Stopped early